Insulet Corp. (PODD)PODDInsulet Corp.

Balance Sheet

Assets, liabilities, and equity analysis

Quarterly Balance Sheet (USD)

Quarterly Report	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024	09/30/2024	06/30/2024
Total Current Assets	1.710B	1.710B	1.889B	1.859B	2.257B	2.307B	1.871B	1.842B	1.731B
Cash & Cash Equivalents	480.400M	480.400M	716.100M	757.400M	992.900M	1.283B	953.400M	902.600M	715.500M
Short-Term Investments	0.00	0.00	0.00	0.00	128.700M	0.00	0.00	0.00	105.500M
Cash & Short-Term Investments	480.400M	480.400M	716.100M	757.400M	1.122B	1.283B	953.400M	902.600M	821.000M
Accounts Receivable	544.700M	544.700M	516.900M	462.200M	444.500M	402.300M	365.500M	375.600M	348.600M
Inventory	462.500M	462.500M	452.600M	446.300M	446.900M	440.800M	430.400M	444.900M	430.900M
Total Assets	2.987B	2.987B	3.190B	3.029B	3.469B	3.517B	3.088B	3.025B	2.882B
Property, Plant & Equipment	830.400M	830.400M	863.200M	724.100M	720.400M	718.700M	759.800M	702.900M	677.900M
Goodwill	51.600M	51.600M	51.600M	51.600M	51.700M	51.500M	51.500M	51.700M	51.700M
Intangible Assets	115.200M	115.200M	117.100M	105.000M	102.300M	99.800M	98.500M	99.600M	98.500M
Long-Term Investments	19.100M	19.100M	20.100M	19.100M	19.100M	1.400M	0.00	0.00	0.00
Total Current Liabilities	687.500M	687.500M	680.100M	647.700M	1.010B	520.400M	528.400M	506.200M	486.000M
Accounts Payable	149.800M	149.800M	75.000M	48.200M	96.100M	57.600M	19.800M	40.300M	76.800M
Short-Term Debt	18.600M	18.600M	22.200M	96.400M	478.400M	83.100M	85.900M	42.000M	37.900M
Total Liabilities	1.685B	1.685B	1.675B	1.645B	2.006B	2.187B	1.876B	1.907B	1.883B
Long-Term Debt	929.500M	929.500M	979.700M	934.900M	939.000M	1.612B	1.296B	1.356B	1.360B
Total Debt	948.100M	948.100M	1.051B	1.031B	1.417B	1.695B	1.422B	1.398B	1.398B
Net Debt (Cash)	467.700M	467.700M	334.700M	273.900M	424.500M	412.300M	468.600M	495.700M	682.300M
Total Shareholders' Equity	1.303B	1.303B	1.515B	1.384B	1.463B	1.331B	1.212B	1.118B	998.400M
Common Stock	100K	100K	100K	100K	100K	100K	100K	100K	100K
Retained Earnings	378.500M	378.500M	287.400M	185.800M	98.200M	75.700M	40.300M	-60.400M	-137.900M
Current Ratio	2.49	2.49	2.78	2.87	2.23	4.43	3.54	3.64	3.56
Debt to Equity Ratio	0.73	0.73	0.69	0.75	0.97	1.27	1.17	1.25	1.40

Annual Balance Sheet (USD)

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Total Current Assets	1.889B	1.871B	1.566B	1.299B	1.317B	1.238B	581.500M	454.009M
Cash & Cash Equivalents	716.100M	953.400M	650.700M	623.900M	791.600M	907.200M	203.700M	113.906M
Short-Term Investments	0.00	0.00	53.500M	50.800M	0.00	40.400M	172.400M	175.040M
Cash & Short-Term Investments	716.100M	953.400M	704.200M	674.700M	791.600M	947.600M	376.100M	288.946M
Accounts Receivable	516.900M	365.500M	359.700M	205.600M	161.000M	83.800M	82.800M	76.672M
Inventory	452.600M	430.400M	402.600M	346.800M	303.200M	154.300M	101.000M	71.414M
Total Assets	3.190B	3.088B	2.588B	2.251B	2.049B	1.873B	1.143B	928.744M
Property, Plant & Equipment	863.200M	759.800M	692.800M	625.900M	546.400M	493.600M	415.500M	258.379M
Goodwill	51.600M	51.500M	51.700M	51.700M	39.800M	39.800M	39.800M	39.646M
Intangible Assets	117.100M	98.500M	98.700M	75.500M	36.600M	28.700M	13.200M	10.383M
Long-Term Investments	20.100M	5.500M	0.00	15.000M	19.300M	14.800M	58.400M	140.784M
Total Current Liabilities	680.100M	528.400M	451.200M	364.700M	228.800M	207.800M	157.700M	115.657M
Accounts Payable	75.000M	19.800M	19.200M	30.800M	37.700M	54.100M	54.500M	25.500M
Short-Term Debt	22.200M	85.900M	52.900M	31.100M	30.100M	20.500M	3.600M	0.00
Total Liabilities	1.675B	1.876B	1.855B	1.775B	1.492B	1.269B	1.067B	716.645M
Long-Term Debt	979.700M	1.296B	1.366B	1.374B	1.249B	1.044B	887.900M	591.978M
Total Debt	1.051B	1.422B	1.449B	1.433B	1.286B	1.076B	905.900M	591.978M
Net Debt (Cash)	334.700M	468.600M	798.100M	808.900M	494.900M	169.000M	702.200M	478.072M
Total Shareholders' Equity	1.515B	1.212B	732.700M	476.400M	556.300M	603.600M	75.900M	212.099M
Common Stock	100K	100K	100K	100K	100K	100K	100K	59K
Retained Earnings	287.400M	40.300M	-378.000M	-584.300M	-649.500M	-666.300M	-672.000M	-683.614M
Current Ratio	2.78	3.54	3.47	3.56	5.75	5.96	3.69	3.93
Debt to Equity Ratio	0.69	1.17	1.98	3.01	2.31	1.78	11.94	2.79

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Insulet Corp.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Acton, MA

5,400 employees

www.insulet.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Ashley A. McEvoy

View full financials